Navigation Links
GeneLink Reports 2012 Financial Results
Date:4/4/2013

ORLANDO, Fla., April 4, 2013 /PRNewswire/ -- GeneLink, Inc. (OTCBB: GNLK.OB, "the Company," or "GeneLink"), a leading consumer genomics biotech company, reports financial results for the fiscal year ended December 31, 2012.

Financial Results:

  • In February of 2012 the Company completed the sale of GeneWize Life Sciences, Inc. to Capsalus Corp (OTCBB: WELL.OB, or "Capsalus"). The sale and accompanying licensing fees provided $1,165,900 to GeneLink during the fiscal year.
  • Annual net sales decreased from $4,684,577 to $2,136,142.  The decrease is primarily related to the sale of GeneWize and the subsequent conversion from retail to wholesale business model in February of 2012.
  • The operating loss in 2012 was $3,468,997.  Most of the loss is attributable to the unsupported overhead costs at GeneLink, establishment of GeneLink's own manufacturing facility, and implementation of plans to support GeneLink's expansion into additional channels.  In addition, we had extraordinary legal expenses related to regulatory compliance.  Net losses for 2012 in the amount of $3,051,747 decreased by $748,449 or 20% compared to 2011.
  • Ongoing cost initiatives resulted in the reduction of 2012 monthly recurring operating expenses by over 50% compared to 2011.
  • Reduced accounts payable during 2012 by over 25%.

Dr. Bernard Kasten , GeneLink's Chairman, CEO and interim CFO stated, "2012 was a continued transition for us as we completed the sale of our direct selling subsidiary, GeneWize.  We were able to utilize the proceeds from that sale to establish a unique and world class manufacturing facility for our customized nutrition and skin care products.  Though the change in our business model from retail to wholesale will initially appear to reduce our revenues, we are hopeful that the our cu
'/>"/>

SOURCE GeneLink, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GeneLink Reports First Quarter 2012 Financial Results
2. GeneLink Reports 2011 Financial Results
3. GeneLink Anticipates Completion of Audit
4. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
5. GeneLink Marketing Efforts Poised to Show Results
6. Global Biomaterial Market: To Grow at a 15% CAGR Says New Research Report at ReportsnReports.com
7. Central Nervous System (CNS) Biomarkers Market: 2017 Forecast in New Research Report at ReportsnReports.com
8. Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results
9. Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012
10. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
11. Neogen reports 27% increase in quarterly net income
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, ... Strategy. In this role, Michelle will work with current and ... the development of iLab products. Her main goal will be ... the scientific community by offering the most advanced, user-friendly, and ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), a ... for patients, physicians, the biopharmaceutical industry, regulators, payers, ... signing of a three-year Research Collaboration Agreement (RCA) ... This initiative is designed to generate disruptive ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental products, has ... arch impressions on its dental blog. , Titled ... serves up a list of tips to help dentists best ... David Little as he crafts a porcelain crown using Kerr’s ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... PAREXEL International Corporation (Nasdaq: PRXL ) will ... January 31, 2011 after the close of the stock market. ... www.PAREXEL.com and on the PR Newswire website at ... and live webcast at 10:00 a.m. EST on Tuesday, February ...
... 2011 Advanced Pain Remedies (APR), a subsidiary of ... has been received, to advance its lead development candidate, ... targeting of specific cell types to manipulate them for ... million grant from the National Cancer Institute (NCI). Advanced ...
... CITY, Kan., Jan. 7, 2011 Aratana Therapeutics, a newly-formed ... animal health industry, today announced that it has closed a ... Avalon Ventures. "At Aratana, we will be focused ... them in new ways to treat and care for animals," ...
Cached Biology Technology:PAREXEL Announces Date of Second Quarter Fiscal Year 2011 Earnings Release and Conference Call 2Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP 2Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP 3
(Date:7/10/2014)... in the West African nation Burkina Faso today ... Sayana Press has the potential to increase access ... system and in communities by combining a lower-dose ... medroxyprogesterone acetate)with the BD Uniject injection system. , ... countries expected to begin introducing Sayana Press in ...
(Date:7/9/2014)... healthy women differ from bacteria in women with ... from Loyola University Chicago Stritch School of Medicine. ... in the American Society for Microbiology,s online journal ... play a role in female urinary health. , ... poorly understood, condition with symptoms similar to urinary ...
(Date:7/9/2014)... Cancer Research Centre (CNIO) have discovered that NANOG, an ... division in stratified epitheliathose that form part of the ... the vaginain adult organisms. According to the conclusions of ... , this factor could also play a role in ... the oesophagus and skin. , The pluripotency factor NANOG ...
Breaking Biology News(10 mins):Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3CNIO scientists discover that pluripotency factor NANOG is also active in adult organisms 2
... the limits of life in extreme environments, scientists have discovered ... an Antarctic lake sealed under more than 65 feet of ... the Proceedings of the National Academy of Sciences , ... been isolated from the surface environment -- and external sources ...
... Johns Hopkins researchers report concrete steps in the use of ... drugs. Their success highlights a pathway toward faster, cheaper drug ... to pre-test a therapy,s safety and effectiveness on cultured clones ... in an article published November 25 on the website of ...
... the first time that marine algae can be just as ... scientists genetically engineered marine algae to produce five different kinds ... used could be employed to enhance the yield of petroleum-like ... in a paper published online in the current issue of ...
Cached Biology News:UIC scientists find ancient microbes in salty, ice-sealed Antarctic lake 2Study advances use of stem cells in personalized medicine 2Bioengineered marine algae expands environments where biofuels can be produced 2